Literature DB >> 7850261

Introduction to bone marrow transplant symposium held at the Albert Einstein Cancer Center at Bronx, NY, USA, March 23 to 25, 1994.

R Gucalp1, J Sparano, J P Dutcher, P H Wiernik.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7850261     DOI： 10.1007/bf02988827

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  13 in total

1.  Autologous transplantation for Hodgkin's disease: coming of age?

Authors:  P J Bierman; J M Vose; J O Armitage
Journal:  Blood       Date:  1994-03-01       Impact factor: 22.113

2.  Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial.

Authors:  D C Linch; D Winfield; A H Goldstone; D Moir; B Hancock; A McMillan; R Chopra; D Milligan; G V Hudson
Journal:  Lancet       Date:  1993-04-24       Impact factor: 79.321

3.  Metastatic interstitial pneumonitis after autologous bone marrow transplantation. A consequence of reinjection of malignant cells?

Authors:  P Glorieux; E Bouffet; I Philip; P Biron; L Holzapfel; D Floret; R Bouvier; D Vitrey; R Pinkerton; M Brunat-Mentigny
Journal:  Cancer       Date:  1986-11-01       Impact factor: 6.860

4.  Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors.

Authors:  W Brugger; K J Bross; M Glatt; F Weber; R Mertelsmann; L Kanz
Journal:  Blood       Date:  1994-02-01       Impact factor: 22.113

5.  Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen.

Authors:  P H Wiernik; J P Dutcher; E Paietta; R Gucalp; S Markus; V Weinberg; C Azar; S Garl; L Benson
Journal:  Leukemia       Date:  1993-08       Impact factor: 11.528

6.  Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an update.

Authors:  I Brodsky; J C Biggs; J Szer; P Crilley; K Atkinson; K Downs; A Dodds; A J Concannon; B R Avalos; P Tutschka
Journal:  Semin Oncol       Date:  1993-08       Impact factor: 4.929

7.  Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s.

Authors:  M M Bortin; M M Horowitz; R P Gale; A J Barrett; R E Champlin; K A Dicke; E Gluckman; H J Kolb; A M Marmont; M Mrsic
Journal:  JAMA       Date:  1992-08-05       Impact factor: 56.272

8.  Evaluating survival after allogeneic bone marrow transplant for chronic myeloid leukaemia in chronic phase: a comparison of transplant versus no-transplant in a cohort of 258 patients first seen in Italy between 1984 and 1986. Italian Cooperative Study Group on Chronic Myeloid Leukaemia.

Authors: 
Journal:  Br J Haematol       Date:  1993-10       Impact factor: 6.998

9.  Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program.

Authors:  P McGlave; G Bartsch; C Anasetti; R Ash; P Beatty; J Gajewski; N A Kernan
Journal:  Blood       Date:  1993-01-15       Impact factor: 22.113

Review 10.  Bone marrow autotransplantation.

Authors:  J O Armitage; R P Gale
Journal:  Am J Med       Date:  1989-02       Impact factor: 4.965
View more
  1 in total

Review 1.  Efficacy and toxicity of radiation in preparative regimens for pediatric stem cell transplantation. I: Clinical applications and therapeutic effects.

Authors:  T D Miale; S Sirithorn; S Ahmed
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.